Ceftriaxone labels and packages: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
Line 31: Line 31:
|}
|}


{|
| [[File:Cefepime package 3.jpeg|400px|thumb]]
|}


{|
| [[File:Cefepime package 4.jpeg|400px|thumb]]
|}
{|
| [[File:Cefepime package 5.jpeg|400px|thumb]]
|}
{|
| [[File:Cefepime package 6.jpeg|400px|thumb]]
|}
{|
| [[File:Cefepime package 7.jpeg|400px|thumb]]
|}




Latest revision as of 18:42, 31 December 2013

Ceftriaxone
CEFTRIAXONE®,ROCEPHIN® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
Clinical Studies
Compatibility and Stability
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

Labels and Packages

Mfg. by:

Hospira Healthcare India Pvt. Ltd.

Irungattukottai - 602 105, India

Mfg. for:

Apotex Corp.

Weston, FL 33326

DATE OF REVISION: JUNE 2011

948026010

949113599-Apotex





References

http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/050796lbl.pdf

|400px|thumb

Retrieved from "https://www.wikidoc.org/index.php?title=Ceftriaxone_labels_and_packages&oldid=922222"